XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property and Equipment, net
12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment, net Property and Equipment, net
Property and equipment, net consists of the following:
As of
Estimated useful lives (Years)December 31, 2021December 31, 2020
Owned Assets:
Network equipment and computers
3-5
$116,023 $107,016 
Software
3-5
101,884 99,708 
Leasehold improvements
3-8
46,401 48,052 
Office furniture and equipment
3-8
22,302 22,210 
Motor vehicles
2-5
693 599 
Buildings
30
1,070 1,089 
Land700 712 
Capital work in progress10,288 4,647 
299,361 284,033 
Less: Accumulated depreciation and amortization(213,699)(191,629)
$85,662 $92,404 
Right-of-use assets under finance leases:*
Network equipment and computers91 93 
Leasehold improvements1,229 817 
Office furniture and equipment787 255 
Motor vehicles578 688 
2,685 1,853 
Less: Accumulated depreciation and amortization(2,339)(1,382)
$346 $471 
Property and equipment, net$86,008 $92,875 
*Depreciation on assets held under finance leases are computed using the straight-line method over the shorter of the asset's estimated useful lives or the lease term.
Capital work in progress represents advances paid towards acquisition of property and equipment and costs incurred on internally developed software, not yet ready to be placed in service.
During the years ended December 31, 2021 and 2020 there were no changes in estimated useful lives of property and equipment during the ordinary course of operations.
The depreciation and amortization expense, excluding amortization of acquisition-related intangibles recognized in the consolidated statements of income was as follows:
Year ended December 31,
202120202019
Depreciation and amortization expense$36,354 $36,050 $30,423 
The effect of foreign exchange gain upon settlement of cash flow hedges recorded under depreciation and amortization, was as follows:
Year ended December 31,
202120202019
Effect of foreign exchange gains$524 $51 $212 
Internally developed software costs, included under Software, was as follows:
As of
December 31, 2021December 31, 2020
Cost$19,289 $18,371 
Less : Accumulated amortization(10,226)(5,998)
Internally developed software, net$9,063 $12,373 
The amortization expense on internally developed software recognized in the consolidated statements of income was as follows:
Year ended December 31,
202120202019
Amortization expense$4,253 $4,894 $2,745 

As of December 31, 2021 and 2020, the Company believes no impairment exists because the long-lived asset's future undiscounted net cash flows expected to be generated exceeds its carrying value; however, there can be no assurances that long-lived assets will not be impaired in future periods. Determining whether an impairment has occurred typically requires various estimates and assumptions, including determining which undiscounted cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount, and the asset’s residual value, if any. It is reasonably possible that the judgments and estimates described above could change in future periods. The duration and severity of COVID-19 and continued market volatility is highly uncertain and, as such, the impact on undiscounted cash flows is subject to significant judgment and may cause variability in the Company’s assessment of the existence of any impairment.
During the year ended December 31, 2019, the Company performed an impairment test of its long-lived assets related to its Health Integrated business. Based on the results, the long-lived assets carrying value exceeded its fair value. The primary factor contributing to a reduction in the fair value is the wind down of the Health Integrated business, due to an anticipated reduction to the Company's estimated future cash flows. As a result of this analysis, the Company recognized impairment charges of $2,178 during the year ended December 31, 2019, to write down the carrying value of property and equipment to its fair value. This impairment charge was recorded in the consolidated statements of income under "Impairment and restructuring charges".